Insilico Medicine

Last updated: August 04, 2024

Alex Zhavoronkov, CEO and co-founder
Alex Zhavoronkov, CEO and co-founder
Hong Kong | Funding: $401.3M (+)

Website: http://insilicomedicine.com/

Insilico aims to apply artificial intelligence to extend human productive longevity and transform the pharmaceutical industry.